On September 26, 2017 OncoSec Medical Incorporated (“OncoSec”) (NASDAQ:ONCS), a company developing DNA-based intratumoral cancer immunotherapies, reported that Punit Dhillon, CEO and President of OncoSec, will present at the Cantor Fitzgerald Global Healthcare Conference on Wednesday, September 27, 2017 at 4:35 PM ET / 1:35 PM PT (Press release, OncoSec Medical, SEP 26, 2017, View Source [SID1234520649]). The conference will take place at the Intercontinental New York Barclay Hotel.